News

Headline News
E-Series 3 pump easy-polymer with logging software screen

Take your E-Series system to the next level with state-of-the-art automation software

Vapourtec's E-Series automation software enhances the E-Series flow chemistry system with touchscreen technology for automated reactions, machine learning support, and integration of external equipment. Key features include data logging, schematic editing, and real-time data graphing, providing advanced control and flexibility for laboratory applications.

Date: 19 July 2024 | Category: Headline NewsNews

Headline News
Vapourtec SF-10+ Lab pump

Turning up the heat with SF-10+ lab pump

The SF-10+ builds on the pump’s existing capabilities, already cited in many scientific breakthroughs since 2016, with enhanced temperature control and can be heated between ambient and 80 °C as well as allowing for the inlet and outlet tubes to be heated to the same temperatu...

Date: 16 November 2023 | Category: Headline NewsNews

Headline News

Twenty-up for pioneering Vapourtec

Flowchem firm celebrates two decades of innovation. Continuous flow synthesis has developed significantly in the 20 years since the formation of UK-based flow chemistry engineering specialists Vapourtec Ltd. Much of the progress and increase in profile for flow chemistry can ...

Date: 10 August 2023 | Category: Headline NewsNews

Headline News

Manuel Nuño talks of the future of peptide synthesis

Vapourtec’s CSO Manuel Nuño explains why the future of peptide synthesis is linked to continuous flow in the latest issue of Speciality Chemicals Magazine. In the article entitled “Continuous flow brings solid-phase peptide synthesis (SPPS) to a new level”

Date: 23 February 2022 | Category: Headline NewsNews

Headline News
RS-400 multiple pump flow chemistry system

Focusing on the evolution of lab automation

The current state of lab automation and its future direction has been brought into focus in a preprint article by the Cambridge Centre for Computational Chemical Engineering (University of Cambridge) entitled “From Platform to Knowledge Graph: Evolution of Laboratory Automation”

Date: 08 December 2021 | Category: Headline NewsNews

Headline News
COVID-19 research

Collaborative DRIVE for COVID-19 treatment

Industry, academia and regulatory agencies are collaborating like never before to carry out COVID-19 research. Developing and testing both existing medicines and medicines in late-stage clinical trials to help patients fight Coronavirus infection.

Date: 01 April 2020 | Category: Headline NewsNews

Headline News

2020 Vision for UV-150 Photochemistry Reactor

Vapourtec’s pioneering UV-150 photochemical reactor has been enhanced with a number of significant advancements. Improvements within the 2020 version include an ability to use reactors  with internal diameters of up to 2.5mm, better solid handling and more.

Date: 08 August 2019 | Category: Headline NewsNews

Headline News
UV-150 mercury photochemical reactor

The Future of Photochemistry with Vapourtec’s UV-150

Vapourtec has developed the UV-150, a pioneering photochemical reactor that will lead to more efficient, precise, consistent, safe and scalable photochemical synthesis offering potential routes for novel compounds and building blocks together with possible new manufacturing processes.

Date: 24 May 2014 | Category: Headline NewsNews

Headline News
Artemisinin

Anti-malarial drug breakthrough

Scientists at the Max Planck institute have unveiled a breakthrough synthesis method for the drug Artimesinin that could make effective malaria treatment affordable for > 200 million worldwide sufferers. The synthesis uses a Vapourtec flow chemistry system and a photo reactor.

Date: 23 May 2014 | Category: Headline NewsNews

Headline News

Sun shines on Vapourtec R-Series down under

Vapourtec’s R-Series flow chemistry system has played its part in another significant breakthrough with the development in Australia of a brand new sun cream based on mimicking the natural protection to sunlight created by coral in the Great Barrier Reef.

Date: 02 April 2014 | Category: Headline NewsNews